Well, if your assumption is right GROK says this about

New Post Public Reply Private Reply Replies (1) Message Board
manfromjax Poseidon360 #32919
337
Well, if your assumption is right GROK says this about shareprice

Estimating the share price valuation for Verb Technology Company, Inc. (VERB) if Q1 2025 revenue surpasses $723,000 involves analyzing available financial data, market dynamics, and valuation metrics. Below is a detailed assessment based on current information and reasonable assumptions, acknowledging the speculative nature of such projections due to limited specific guidance and market volatility.
Key Data Points
Q4 2024 Revenue: $723,000, with total 2024 revenue of $895,000 (1,321% year-over-year growth).

Current Stock Price: Approximately $4.41 as of April 24, 2025, with a market cap of $4.91 million (1,113,143 shares outstanding).

Price-to-Sales (P/S) Ratio: Based on 2024 revenue of $895,000 and a market cap of $4.93 million as of March 11, 2025, the trailing P/S ratio is approximately 5.51 ($4.93M / $0.895M).

Analyst Revenue Forecast for 2025: $1,191,685 annually, implying ~$297,921 per quarter if evenly distributed, though Verb expects to exceed Q4 2024’s $723,000 in Q1 2025.

Recent Performance: Q4 2024 revenue grew 465% quarter-over-quarter from $128,000 in Q3 2024. Strategic initiatives (MARKET.live, Go Fund Yourself, LyveCom acquisition, telehealth vertical) are expected to drive further growth.

Balance Sheet: $15.8 million in cash and investments, $18.03 million in stockholder equity as of Q3 2024, supporting growth initiatives.

Price-to-Book (P/B) Ratio: 0.31 as of Q4 2024, suggesting potential undervaluation relative to assets.

Analyst Price Target: One analyst suggests a 12-month target of $800.00, though this appears speculative and inconsistent with current metrics.

Revenue Scenarios for Q1 2025
Since Verb expects Q1 2025 revenue to surpass $723,000, let’s consider two plausible scenarios based on historical growth trends and strategic developments:
Conservative Scenario: Revenue of $800,000, a 10.5% increase from Q4 2024, reflecting steady growth from MARKET.live ($490,000 in Q4), Go Fund Yourself ($233,000 in Q4), and contributions from LyveCom and telehealth.

Optimistic Scenario: Revenue of $900,000, a 24.5% increase, assuming accelerated growth from expanded marketing, new verticals, and synergies from the LyveCom acquisition completed in April 2025.

Valuation Approach
To estimate the share price, we’ll use the Price-to-Sales (P/S) ratio, a common metric for high-growth, pre-profit tech companies like Verb, and cross-check with the Price-to-Book (P/B) ratio to assess asset-based valuation. We’ll also consider market sentiment and qualitative factors.
1. P/S-Based Valuation
Current P/S Ratio: 5.51, based on 2024 revenue and market cap.

Assumption: The market may maintain a similar P/S ratio or increase it slightly (e.g., to 6.0–7.0) if Q1 2025 results exceed expectations, reflecting optimism about Verb’s growth trajectory.

Step 1: Estimate Annualized Revenue
For Q1 2025 revenue of $800,000, assume steady performance across quarters, leading to annualized revenue of ~$3.2 million ($800,000 × 4).

For Q1 2025 revenue of $900,000, annualized revenue is ~$3.6 million ($900,000 × 4).

Step 2: Calculate Market Cap
Conservative Scenario ($800,000 Q1 revenue):
At P/S = 5.51: Market cap = $3.2M × 5.51 = $17.63 million.

At P/S = 6.0: Market cap = $3.2M × 6.0 = $19.2 million.

At P/S = 7.0: Market cap = $3.2M × 7.0 = $22.4 million.

Optimistic Scenario ($900,000 Q1 revenue):
At P/S = 5.51: Market cap = $3.6M × 5.51 = $19.84 million.

At P/S = 6.0: Market cap = $3.6M × 6.0 = $21.6 million.

At P/S = 7.0: Market cap = $3.6M × 7.0 = $25.2 million.

Step 3: Calculate Share Price
Shares outstanding: 1,113,143.

Share price = Market cap ÷ Shares outstanding.

Conservative Scenario:
P/S = 5.51: $17.63M ÷ 1,113,143 = ~$15.84.

P/S = 6.0: $19.2M ÷ 1,113,143 = ~$17.25.

P/S = 7.0: $22.4M ÷ 1,113,143 = ~$20.12.

Optimistic Scenario:
P/S = 5.51: $19.84M ÷ 1,113,143 = ~$17.83.

P/S = 6.0: $21.6M ÷ 1,113,143 = ~$19.41.

P/S = 7.0: $25.2M ÷ 1,113,143 = ~$22.64.

2. P/B-Based Valuation
Current P/B Ratio: 0.31, with stockholder equity of $18.03 million as of Q3 2024.

Book Value per Share: $18.03M ÷ 1,113,143 = ~$16.20.

Current Share Price: $4.41, implying the market significantly discounts Verb’s assets, possibly due to profitability concerns or market skepticism.

If Q1 2025 revenue surpasses $723,000, positive market sentiment could push the P/B ratio closer to 1.0 (typical for tech firms with growth potential):
At P/B = 0.5: Share price = $16.20 × 0.5 = ~$8.10.

At P/B = 0.75: Share price = $16.20 × 0.75 = ~$12.15.

At P/B = 1.0: Share price = $16.20 × 1.0 = ~$16.20.

3. Analyst and Market Sentiment
Analyst Price Target: One analyst’s $800.00 target seems unrealistic given current financials and market cap, likely reflecting speculative enthusiasm rather than fundamentals.

Recent Stock Performance: Despite Q4 2024’s strong revenue, the stock fell 8.41% to $5.01 in aftermarket trading, suggesting investor caution or profit-taking.

X Sentiment: A post on May 9, 2025, suggested short-term price targets of $6.43, $7.60, and $9.36, indicating some bullish sentiment among traders.

Market Dynamics: Verb’s low float (<800,000 shares post-split) and history of volatility (52-week range: $3.81–$40.30) suggest potential for significant price swings if Q1 2025 results exceed expectations.

Critical Analysis
Bullish Factors:
Strong revenue growth (465% Q3 to Q4 2024) and diversified streams (MARKET.live, Go Fund Yourself, telehealth, LyveCom) support the expectation of surpassing $723,000.

A low P/B ratio (0.31) and high cash reserves ($15.8M) suggest undervaluation and financial stability, potentially attracting value investors.

Strategic partnerships (TikTok, Meta, Cheddar TV) and the LyveCom acquisition could enhance revenue and market perception.

Bearish Factors:
Persistent losses (Q4 2024 net loss: $3.19M, EPS: -$3.463 vs. -$2.52 estimate) and high cash burn raise concerns about profitability.

Analyst forecasts of a 2025 sales decline (to $1.19M annually) contrast with Verb’s optimism, creating uncertainty.

Recent stock price declines despite strong Q4 results indicate market skepticism or manipulation concerns (e.g., short-selling post-reverse split).

Risks: The micro-cap nature of Verb ($4.91M market cap) and high volatility (9.53%, beta 1.15) make it susceptible to sharp price movements. Failure to achieve profitability or execute on new verticals could cap upside.

Estimated Share Price Valuation
Combining P/S and P/B approaches with market sentiment:
Conservative Estimate ($800,000 Q1 revenue):
P/S-based (5.51–6.0): $15.84–$17.25.

P/B-based (0.75): $12.15.

Weighted estimate (favoring P/S due to growth focus): ~$14.00–$16.00.

Optimistic Estimate ($900,000 Q1 revenue):
P/S-based (6.0–7.0): $19.41–$22.64.

P/B-based (1.0): $16.20.

Weighted estimate: ~$18.00–$20.00.

Final Answer
If Verb Technology’s Q1 2025 revenue surpasses $723,000, the share price could reasonably be valued at:
$14.00–$16.00 in a conservative scenario (e.g., $800,000 revenue), reflecting steady growth and modest market optimism.

$18.00–$20.00 in an optimistic scenario (e.g., $900,000 revenue), assuming strong execution and improved sentiment.
These estimates assume no major market disruptions or negative earnings surprises (e.g., wider losses). Investors should monitor the May 20, 2025, earnings report for confirmation of revenue and profitability trends.


Disclaimer: This valuation is speculative and based on limited public data. Stock prices are influenced by unpredictable factors, including market sentiment, macroeconomic conditions, and company-specific risks. Always conduct independent research and consult financial advisors before investing.

TON Strategy Co. (TONX) Stock Research Links

TONX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Epic Political Thriller Explores Humanity's Future

Updated Category News Views 2

Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...

Continue Reading
Cala Launches Game-Changer Wearable for Tremor Relief

Updated Category News Views 7

Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...

Continue Reading
Purina Institute Highlights Nutritional Science at WSAVA 2026

Updated Category News Views 6

A Global Stage for Pet Nutrition Science The folks over at the Purina Institute are back in the spotlight as they gear up to throw their weight behind the 51st World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. Set for October 13-15, 2026, this isn’t just another event—they're bringing some serious clout with their 'Food for Thought'...

Continue Reading
NYSE Texas Redefines the U.S. Capital Markets Landscape

Updated Category News Views 9

NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...

Continue Reading
ROKFORM’s Signal Card: A Wallet Tracker for All

Updated Category News Views 4

The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...

Continue Reading
Karoo Health Leaps Forward with New CCO Breton

Updated Category News Views 4

Change of Guard in Cardiac Health at Karoo Here's a move that might shake things up in the healthtech sector: Karoo Health just snagged Angela "Angie" Breton as their new Chief Commercial Officer. It's like putting a seasoned captain at the helm right before setting sail on uncharted waters. Breton's not just any captain—she's got a hefty 25 years of experience...

Continue Reading
Charter Next Generation Unveils Gen 2 MDO-PE Films

Updated Category News Views 4

Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...

Continue Reading
Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

Updated Category News Views 2

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Continue Reading
Pushing for National Liver Cancer Awareness in 2026

Updated Category News Views 4

The Urgency of Liver Cancer Awareness Death doesn’t wait, does it? When liver cancer is the villain in question, every moment becomes precious because this beast doesn’t roar until it’s too late. Here we are in 2026, staring at nearly 31,000 annual deaths in the U.S. alone. But hope flickers with a new congressional resolution aiming to slap a bright spotlight on...

Continue Reading
Navigating Holiday Sweets: Healthy Balancing Acts

Updated Category News Views 3

In the middle of the sweet madness that is the holiday season, Crispy Green and Dr. Nicole Avena are playing guide to families drowning in sugar. This isn't just a once-a-year Halloween headache; we're starting that sugar spiral early and letting it ride until the New Year approaches. It's an all-hands-on-deck situation if families want to dodge that sugar overload. Why...

Continue Reading

Top 5 Most Recently Viewed Articles

ETHRANSACTION Unveils Innovative Cloud Mining Solutions

Updated Category News Views 189

ETHRANSACTION Cloud Mining Platform Introduces Smart Contracts Though recent weeks have shown significant fluctuations in Bitcoin prices, many investors are gravitating towards safer investment options within the crypto landscape. Recognizing this trend, the ETHRANSACTION Cloud Mining Platform has stepped up to offer innovative solutions catered to those eager to explore...

Continue Reading
Seattle Children's Hospital Earns Prestigious National Honor

Updated Category News Views 253

Seattle Children's Ranked Among Top Hospitals in the Country Seattle Children's shines in Washington state rankings and excels in the Pacific region. Seattle Children's has proudly made the prestigious Best Children's Hospitals 2025-2026 Honor Roll released by U.S. News & World Report, earning a spot among the top 10 children’s hospitals in the nation. This accolade is...

Continue Reading
Huawei Unveils Global Alliance for Education and Healthcare

Updated Category News Views 206

Huawei Launches Global Education and Healthcare Partner Alliance Huawei recently introduced the Global Education and Healthcare Partner Alliance (GEHPA) during an exceptional event. The initiative, aiming to enhance collaboration within the industry, welcomed over 300 partners from various countries. By leveraging shared strengths and resources, GEHPA sets out to create a...

Continue Reading
Smartsheet Observes Noteworthy Insider Transaction and Growth

Updated Category News Views 114

Noteworthy Insider Transaction at Smartsheet Smartsheet Inc. (NYSE: SMAR), a leader in cloud-based work collaboration software, recently captured attention when Chief Operating Officer Stephen Robert Branstetter sold a portion of his company shares. Specifically, Branstetter sold 1,847 shares of Class A Common Stock at a price of $53.00 each, bringing in a total of...

Continue Reading
CMB.TECH and Golden Ocean Merger Progress Report

Updated Category News Views 141

Progress Report on CMB.TECH and Golden Ocean Merger Recently, CMB.TECH NV (NYSE: CMBT & Euronext Brussels: CMBT) provided valuable insights into the ongoing merger process with Golden Ocean Group Limited (NASDAQ: GOGL). This stock-for-stock transaction entails Golden Ocean merging into CMB.TECH Bermuda Ltd., a fully-owned subsidiary of CMB.TECH, where CMB.TECH Bermuda...

Continue Reading